T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
United Kingdom
21787116.9
Filed on 2023-03-28
21787116.9
Filed on 2023-03-28
ANTI-THYROGLOBULIN T CELL RECEPTORS
United Kingdom
20208238.4
Filed on 2020-11-17
20208238.4
Filed on 2020-11-17
ANTI-THYROGLOBULIN T CELL RECEPTORS
Germany
20208238.4
Filed on 2020-11-17
20208238.4
Filed on 2020-11-17
ANTI-THYROGLOBULIN T CELL RECEPTORS
France
20208238.4
Filed on 2020-11-17
20208238.4
Filed on 2020-11-17
T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME
US Application 19/486,754
Filed on 2025-11-21
Filed on 2025-11-21
IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN
US Application 19/410,830
Filed on 2025-12-05
Filed on 2025-12-05
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Cyprus
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE
FAMILY AND USE IN ANTI-CANCER THERAPIES
US Application 19/502,979
Filed on 2026-01-16
Filed on 2026-01-16
IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES
Australia
2024296108
Filed on 2026-02-09
2024296108
Filed on 2026-02-09